CASTELLI, CARLOTTA
CASTELLI, CARLOTTA
Dipartimento di Biologia
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV.
2024-01-01 Magnapera, 1a; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Salpini, R; Svicher, V
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity.
2024-01-01 Piermatteo, 1l; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity.
2025-01-01 D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R
Clinical and laboratory parameters correlated to HDV undetectability after 48 weeks of bulevirtide
2025-01-01 Di Lorenzo, N; D’Anna, S; Kontogiannis, D; Sorace, C; Crea, A; Teti, E; Malagnino, V; Piermatteo, L; Grossi, I; Castelli, C; Carreri, B; Nezzo, M; Salbuzzi, F; Iannetta, M; Geretti, A; Svicher, V; Salpini, R; Sarmati, L
Cryptic HBV activity is frequently observed among anti-HBc positive/HBsAg negative people living with HIV infection during HBV-active art and can jeopardize the full control of HIV replication.
2024-01-01 Piermatteo, L; Salpini, R; D’Anna, S; Castelli, C; Grossi, I; Mulas, T; Di Lorenzo, A; Bertoli, A; Iannetta, M; Sarmati, L; Svicher, V; Malagnino., V
Despite a substantial burden of HDV infection, gaps in HDV screening still persists across Europe: an urgent need to strengthen diagnostic strategies at pan-European level
2025-01-01 Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Iserentant, G; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V
HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential.
2025-01-01 D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Castelli, C; Magnapera, A; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
Persistent HBV cryptic activity is frequently revealed among anti-HBc positive/HBsAg negative people living with HIV infection during HBV-active ART and can jeopardize the full control of HIV replication.
2024-01-01 Piermatteo, 1l; Salpini, R; D’Anna, S; Castelli, C; Grossi, I; Mulas, T; Di Lorenzo, A; Bertoli, A; Iannetta, M; Sarmati, L; Svicher, V; Malagnino Oral presentation at -, V
The burden of HDV chronic infection and the gaps in HDV screening across Europe: an urgent need to strengthen diagnostic strategies at pan-European level
2025-01-01 Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Seguin-Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2024 | A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. | Magnapera, 1a; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. | Piermatteo, 1l; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 1-gen-2025 | Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. | D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2025 | Clinical and laboratory parameters correlated to HDV undetectability after 48 weeks of bulevirtide | Di Lorenzo, N; D’Anna, S; Kontogiannis, D; Sorace, C; Crea, A; Teti, E; Malagnino, V; Piermatteo, L; Grossi, I; Castelli, C; Carreri, B; Nezzo, M; Salbuzzi, F; Iannetta, M; Geretti, A; Svicher, V; Salpini, R; Sarmati, L | Intervento a convegno | |
| 1-gen-2024 | Cryptic HBV activity is frequently observed among anti-HBc positive/HBsAg negative people living with HIV infection during HBV-active art and can jeopardize the full control of HIV replication. | Piermatteo, L; Salpini, R; D’Anna, S; Castelli, C; Grossi, I; Mulas, T; Di Lorenzo, A; Bertoli, A; Iannetta, M; Sarmati, L; Svicher, V; Malagnino., V | Intervento a convegno | |
| 1-gen-2025 | Despite a substantial burden of HDV infection, gaps in HDV screening still persists across Europe: an urgent need to strengthen diagnostic strategies at pan-European level | Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Iserentant, G; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential. | D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Castelli, C; Magnapera, A; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | Persistent HBV cryptic activity is frequently revealed among anti-HBc positive/HBsAg negative people living with HIV infection during HBV-active ART and can jeopardize the full control of HIV replication. | Piermatteo, 1l; Salpini, R; D’Anna, S; Castelli, C; Grossi, I; Mulas, T; Di Lorenzo, A; Bertoli, A; Iannetta, M; Sarmati, L; Svicher, V; Malagnino Oral presentation at -, V | Intervento a convegno | |
| 1-gen-2025 | The burden of HDV chronic infection and the gaps in HDV screening across Europe: an urgent need to strengthen diagnostic strategies at pan-European level | Salpini, R; Grossi, I; Alexiev, I; Baiocchi, L; Banica, L; Begovac, J; Benkoova, B; Bopegamage, S; Castelli, C; Caudai, C; D’Anna, S; Demir, T; Seguin-Devaux, C; Di Lorenzo, A; Heger, E; Kaiser, R; Kokkinos, N; Fernandez-Rivas, G; Gazdikova, K; Geretti, Am; Golkocheva-Markova, E; Lazarevic, I; Lazureanu, V; Leuzinger, K; Lindh, M; Llibre, Jm; Lunar, Mm; Mihale, J; Mor, O; Nierhoff, D; Otelea, D; Piermatteo, L; Poljak, M; Riccio, Arm; Sarmati, L; Torre, G; Tudor, Am; Vata, A; Yildiran, D; Zazzi, M; Wensing, Amj; Svicher, V | Intervento a convegno |